secwatch.observer — SEC 8-K summary
======================================

Issuer:     ECOLAB INC. (ECL)
CIK:        0000031462
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0001558370-24-006197
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ecolab Q1 adj EPS $1.34 (+52%); raises FY guide to $6.40-$6.70; sells surgical unit for $950M
--------------------------------------------------------------------------------

- Adjusted diluted EPS $1.34, +52% YoY; reported diluted EPS $1.43, +74%.
- Organic sales +5% to $3.72B; organic operating margin +400 bps to 14.7%.
- Sale of global surgical solutions to Medline for $950M cash; expected close H2 2024.
- FY2024 adjusted EPS guidance raised to $6.40-$6.70, +23-29% versus prior $6.10-$6.50.
- Institutional & Specialty organic sales +11%, operating income +90% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/31462/000155837024006197/0001558370-24-006197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/31462/000155837024006197/ecl-20240430x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-006197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer